February 7, 2025
Decentralized Trials Must Put Patients First—Not Just Technology
At EUCROF 2025 in Copenhagen, Monique Dugueperoux, our Business Development Manager, attended a panel discussion on home trial services, where key stakeholders—sponsors, patients, sites, CROs, and health authorities—shared insights on the future of decentralized clinical trials (DCTs).
💡 Patients’ voices must remain central in decentralized clinical trials (DCTs).
The rise of decentralized trials has brought significant advancements in clinical research, from remote patient monitoring to digital tools that streamline data collection. But as technology continues to shape the future of trials, one critical question remains: Are we truly designing trials with patients in mind?
True innovation goes beyond digital solutions. Trials must be accessible, inclusive, and designed with patients in mind. The discussion at EUCROF 2025 reinforced the need to balance innovation, compliance, and real-world patient needs to ensure DCTs work for everyone.
As decentralized trials continue to evolve, keeping patient voices at the core will be essential. Meaningful change happens when all stakeholders—sponsors, sites, regulators, and, most importantly, patients—collaborate to shape the future of clinical research. How can the industry strike the right balance between innovation, compliance, and patient engagement? These discussions are just the beginning.